TMCnet News

Research and Markets: Pharmaceutical Market: Colombian Overview 2015
[September 25, 2015]

Research and Markets: Pharmaceutical Market: Colombian Overview 2015


Research and Markets (http://www.researchandmarkets.com/research/x8wlts/the) has announced the addition of the "The Pharmaceutical Market: Colombia" report to their offering.

Improvements in Colombia's pharmaceutical regulation system will expand local patients' access to medicines. However, it will also put pricing pressures on drug-makers, and promote the use of generic versions, which will undermine the growth of patented drug market. Nevertheless, this report expects more foreign pharmaceutical companies to invest in Colombia, capitalising on the country's strong long-term growth prospects.

Risk/Reward Rating:

Despite a 3%quarter-on-quarter (q-o-q) improvement in its composite score, Colombia slipped from sixth to seventh place out of the 17 countries surveyed in the Americas region. Nevertheless, we retain our positive view of Colombia's longer-term commercial opportunities for pharmaceutical companies, which are supported by factors such as substantial population numbers, steady economic development and underdeveloped pharmaceutical demand. On a negative note, we continue to view intellectual property (IP) shortcomings as problematic.



Companies Mentioned

- GlaxoSmithKline


- Laboratorios Bussi-

- Laboratorios Genfar SA

- Lafrancol

- Merck & Co

- Novartis

- Pfizer

- Sanofi

- Tecnoqu-micas

For more information visit http://www.researchandmarkets.com/research/x8wlts/the

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To TMCnet.com's Homepage ]